Page last updated: 2024-11-12

2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone: RN given refers to unlabeled cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10093628
SCHEMBL ID8583021
MeSH IDM0138373

Synonyms (18)

Synonym
2-[[2-(4-hydroxy-3-iodophenyl)ethylamino]methyl]-3,4-dihydro-2h-naphthalen-1-one
2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone
1(2h)-naphthalenone, 3,4-dihydro-2-(((2-(4-hydroxy-3-iodophenyl)ethyl)amino)methyl)-
i-heat
iheat
2-(beta-(4-hydroxy-3-iodophenyl)ethylaminomethyl)tetralone
i(125)-heat
ibe 2254
95034-25-6
unii-3egk3znd2l
3egk3znd2l ,
m-iodo-heat
SCHEMBL8583021
2-((2-(4-hydroxy-3-iodanylphenyl)ethylamino)methyl)-3,4-dihydro-2h-naphthalen-1-one
2-(p-(4-hydroxy-3-(125i)iodophenyl)ethylaminomethyl)-tetralone
ibe-2254
Q27257113
AKOS040752057

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The dose-response relationship for norepinephrine-induced [Ca2+]i response showed an increase in maximum effect with no change in agonist potency, and the increase in maximum effect was disproportionate to the difference in receptor density."( Effect of receptor density on the receptor-effector coupling: use of cloned and stably expressed alpha 1B-adrenoceptors in CHO cells.
Horie, K; Tsujimoto, G, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (35.29)18.7374
1990's15 (44.12)18.2507
2000's5 (14.71)29.6817
2010's2 (5.88)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.76 (24.57)
Research Supply Index3.58 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other35 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]